Eslovàquia - eslovac - ŠÚKL (Štátny ústav pre kontrolu liečiv)

gedeon richter plc., maďarsko - drospirenón a etinylestradiol - 17 - anticoncipientia

Eslovàquia - eslovac - ŠÚKL (Štátny ústav pre kontrolu liečiv)

gedeon richter plc., maďarsko - drospirenón a etinylestradiol - 17 - anticoncipientia

Eslovàquia - eslovac - ŠÚKL (Štátny ústav pre kontrolu liečiv)

zentiva, k.s., Česká republika - levocetirizín - 24 - antihistaminica, histamin

Unió Europea - eslovac - EMA (European Medicines Agency)

roche registration gmbh  - entrectinib - cancer; carcinoma, non-small-cell lung - antineoplastické činidlá - rozlytrek as monotherapy is indicated for the treatment of adult and paediatric patients 12 years of age and older with solid tumours expressing a neurotrophic tyrosine receptor kinase (ntrk) gene fusion,who have a disease that is locally advanced, metastatic or where surgical resection is likely to result in severe morbidity, andwho have not received a prior ntrk inhibitorwho have no satisfactory treatment options. rozlytrek as monotherapy is indicated for the treatment of adult patients with ros1 positive, advanced non small cell lung cancer (nsclc) not previously treated with ros1 inhibitors.

Unió Europea - eslovac - EMA (European Medicines Agency)

alfasigma s.p.a. - metyltioníniumchlorid - colorectal neoplasms; colonoscopy - other diagnostic agents - lumeblue is indicated as a diagnostic agent enhancing visualisation of colorectal lesions in adult patients undergoing screening or surveillance colonoscopy.

Unió Europea - eslovac - EMA (European Medicines Agency)

eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - antineoplastické činidlá - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.

Eslovàquia - eslovac - ŠÚKL (Štátny ústav pre kontrolu liečiv)

mcneil ab, Švédsko - nikotín - 87 - varia i

Unió Europea - eslovac - EMA (European Medicines Agency)

amicus therapeutics europe limited - cipaglucosidase alfa - glykogénová choroba typu ii - iné alimentárny trakt a metabolizmus výrobky, - pombiliti (cipaglucosidase alfa) is a long-term enzyme replacement therapy used in combination with the enzyme stabiliser miglustat for the treatment of adults with late-onset pompe disease (acid α-glucosidase [gaa] deficiency).

Eslovàquia - eslovac - ŠÚKL (Štátny ústav pre kontrolu liečiv)

egis pharmaceuticals plc, maďarsko - klobetazol - 46 - dermatologica

Unió Europea - eslovac - EMA (European Medicines Agency)

takeda manufacturing austria ag - octocog alfa - hemofília a - antihemoragiká - liečba a profylaxia krvácania u pacientov s hemofíliou a (vrodená deficiencia faktora viii). advate neobsahuje von willebrand faktor v farmakologicky účinných množstvách, a preto nie je uvedené v von willebrand ochorenia.